Physician-guided care in Florida and ColoradoFL (954) 953-3662  |  CO (720) 902-8247
Home / Services / Tirzepatide Weight Loss

Tirzepatide Weight Loss

A weekly dual GIP/GLP-1 medication, available to start in-office at both clinics.

Quick answer: Tirzepatide acts on two hormone pathways, GIP and GLP-1, to reduce appetite and improve how your body handles blood sugar. Brand-name tirzepatide (Zepbound) is FDA-approved for chronic weight management in qualifying adults.

How it works

  1. Evaluation. Your clinician confirms that tirzepatide is appropriate for you, based on your history, labs where needed, and current medications.
  2. Personalized dosing. Doses increase in steps over several weeks, so the medication works while side effects stay manageable.
  3. Nutrition and strength. We help you eat enough protein and stay active so that the weight you lose is mostly fat, not muscle.
  4. Follow-up. Scheduled visits track your weight, body composition, side effects and next steps.

Important to know

Common side effects include nausea, diarrhea, constipation and stomach discomfort. Tirzepatide carries a boxed warning about thyroid C-cell tumors and is not appropriate for people with certain medical histories or who are pregnant. It may reduce the effectiveness of oral birth control pills. Your clinician will review all of this with you.

Questions

What is the difference between semaglutide and tirzepatide?
Semaglutide targets the GLP-1 pathway. Tirzepatide targets both GIP and GLP-1. Which one suits you depends on your health, your goals and how you respond. Your clinician will help you decide.
Can I start the same day?
Often, yes, after your evaluation, if the clinician finds it appropriate. Availability can vary by location and day, so call or book ahead to confirm.
Is tirzepatide FDA-approved?
Brand-name tirzepatide (Zepbound) is FDA-approved for chronic weight management in qualifying adults. Compounded versions are not FDA-approved. Your clinician will explain which product they are prescribing.

Guides on this topic

Important information. Semaglutide and tirzepatide are prescription medications. Brand-name versions are FDA-approved for chronic weight management in qualifying adults. Compounded preparations, where a clinician determines one is medically appropriate, are not FDA-approved and are not evaluated by the FDA for safety, effectiveness or quality. Important safety information, including boxed warnings about thyroid C-cell tumors, is provided by your clinician and in the manufacturer prescribing information. Results vary from person to person and are not guaranteed. Whether a treatment is appropriate for you is a medical decision made by a licensed clinician after an evaluation.